SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical and Applied Thrombosis/Hemostasis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Metz, J.
Right arrow Articles by McGrath, K. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Metz, J.
Right arrow Articles by McGrath, K. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Prevalence of Factor V Leiden Is Not Increased in Women with Recurrent Miscarriage

Jack Metz, M.D.

Department of Hematology, Royal Women's Hospital

Michael Kloss, M.B.

Department of Obstetrics, Royal Women's Hospital

Cindy J. O'Malley, B.App.Sc.

Department of Diagnostic Hematology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

Steven P. Rockman, M.Sc.

Department of Diagnostic Hematology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

Lidia DeRosa, B.App.Sc.

Department of Hematology, Royal Women's Hospital

Rowan G. Doig, M.B.

Department of Diagnostic Hematology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

Kathefine M. McGrath, M.B.

Department of Diagnostic Hematology, Royal Melbourne Hospital, Melbourne, Victoria, Australia

The purpose of this study was to determine if there is an increased prevalence of the thrombophilic genetic mutant factor V Leiden in patients with recurrent miscarriage. Functional assays were conducted for activated protein C resistance and genetic detection of factor V Leiden in 100 women with recurrent miscarriage compared with a control group. The prevalence of factor V Leiden in patients was 6/100 (6%) compared with 3/85 (3.5%) in controls. The difference was not statistically significant. Antithrombotic prophylaxis with heparin and/ or aspirin in a subsequent pregnancy in five of the six patients with factor V Leiden was associated with maintenance of pregnancy and delivery of a live, healthy, full-term infant in four. We have been unable to demonstrate a statistically significant increased prevalence of factor V Leiden in women with recurrent miscarriage. If antithrombotic prophylaxis in pregnancy can be shown by controlled therapeutic trial to prevent miscarriage in these patients, identification of this subgroup would be important. Key Words: Recurrent miscarriage—Factor V Leiden—Activated protein C resistance.

Clinical and Applied Thrombosis/Hemostasis, Vol. 3, No. 2, 137-140 (1997)
DOI: 10.1177/107602969700300213
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement